The role of anti-IgE therapies in the treatment of asthma
- 1 August 2002
- journal article
- review article
- Published by Mark Allen Group in Hospital Medicine
- Vol. 63 (8) , 483-486
- https://doi.org/10.12968/hosp.2002.63.8.1969
Abstract
The prevalence of asthma, a chronic inflammatory disease often linked to allergy, is on the increase. The introduction of a blocking anti-IgE monoclonal antibody (omalizumab) as a new therapy has not only confirmed the pathogenic role of IgE in asthma but has also provided a novel therapy for a chronic severe disease where there are limited therapeutic options.Keywords
This publication has 15 references indexed in Scilit:
- Omalizumab, a novel anti-IgE therapy in allergic disordersExpert Opinion on Biological Therapy, 2001
- Spiral Computed Tomography Screening for Lung Cancer Is Ready for Prime TimeAmerican Journal of Respiratory and Critical Care Medicine, 2001
- The role of intervention in established allergy: Avoidance of indoor allergens in the treatment of chronic allergic diseaseJournal of Allergy and Clinical Immunology, 2000
- Do allergies protect against the effects of a rhinovirus cold?Journal of Allergy and Clinical Immunology, 2000
- Treatment of Allergic Asthma with Monoclonal Anti-IgE AntibodyNew England Journal of Medicine, 1999
- How much asthma is really attributable to atopy?Thorax, 1999
- Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody.The Journal of Experimental Medicine, 1996
- Genetic Susceptibility to Asthma — Bronchial Hyperresponsiveness Coinherited with a Major Gene for AtopyNew England Journal of Medicine, 1995
- Inhibition of Allergic Reactions with Antibodies to IgEInternational Archives of Allergy and Immunology, 1995
- Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergiesProtein Engineering, Design and Selection, 1993